Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4653 Target Snapshot

Dipeptidyl peptidase 4 · SINGLE PROTEIN · Rattus norvegicus

315Compounds
71Assays
4Approved Drugs
244.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P14740. Use UniProt P14740 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P14740 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Dipeptidyl peptidase 4 as ChEMBL target CHEMBL4653, mapped to UniProt P14740. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Dipeptidyl peptidase 4
SINGLE PROTEIN · Rattus norvegicus
As of 2026-09-13
ChEMBL target ID
CHEMBL4653
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P14740
Dipeptidyl peptidase 4
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Dipeptidyl peptidase 4 is the right protein anchor across sources, using UniProt P14740 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelDipeptidyl peptidase 4
UniProt AccessionP14740
Component TypeProtein
Sequence Length767 aa

Dipeptidyl peptidase 4

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Dipeptidyl peptidase 4, mapped to UniProt P14740. Sequence length is 767 aa.

Mapped IDP14740
Review nameDipeptidyl peptidase 4
OrganismRattus norvegicus
Clinical Profile

Clinical Phase Distribution

4
Approved
Assay Mix

Activity Type Distribution

IC50236.0
KI8.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL445437 9.89 IC50 0.13 Preclinical
CHEMBL194717 9.82 IC50 0.15 Preclinical
CHEMBL370540 9.77 IC50 0.17 Preclinical
CHEMBL370046 9.77 IC50 0.17 Preclinical
CHEMBL456420 9.77 IC50 0.17 Preclinical
CHEMBL2147704 9.74 IC50 0.18 Preclinical
CHEMBL2147703 9.72 IC50 0.19 Preclinical
CHEMBL433811 9.62 IC50 0.24 Preclinical
CHEMBL371143 9.59 IC50 0.26 Preclinical
CHEMBL195420 9.57 IC50 0.27 Preclinical
Distribution

pChEMBL Value Distribution

13
5.0
20
5.5
13
6.0
19
6.5
22
7.0
34
7.5
25
8.0
35
8.5
18
9.0
13
9.5
pChEMBL
Approved Drugs

Approved Drugs

GOSOGLIPTIN
CHEMBL515387
Approved 2016
OMARIGLIPTIN
CHEMBL2105762
Approved 2015
TENELIGLIPTIN
CHEMBL2147777
Approved 2012
SITAGLIPTIN
CHEMBL1422
Approved 2006
Assay Landscape

Assay Landscape

71
Total Assays
215
Tested Compounds
3
Assay Types
Binding — 45 assays, 215 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 23 96 7.2
cell-free format 14 116 7.8
organism-based format 4 0
microsome format 2 0
assay format 1 0
tissue-based format 1 3 4.2
Functional — 24 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
organism-based format 10 0
assay format 7 0
cell-free format 7 0
ADME — 2 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-free format 1 0
single protein format 1 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine